These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 18365957

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Relapses and progression of disability in multiple sclerosis.
    Confavreux C, Vukusic S, Moreau T, Adeleine P.
    N Engl J Med; 2000 Nov 16; 343(20):1430-8. PubMed ID: 11078767
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The clinical course of multiple sclerosis patients in Hong Kong.
    Lau KK, Wong WW, Sheng B, Yu IT, Fung BH, Li HL, Ma KF, Wong LK, Li PC.
    J Neurol Sci; 2008 May 15; 268(1-2):78-82. PubMed ID: 18068191
    [Abstract] [Full Text] [Related]

  • 30. Limb apraxia in multiple sclerosis: prevalence and impact on manual dexterity and activities of daily living.
    Kamm CP, Heldner MR, Vanbellingen T, Mattle HP, Müri R, Bohlhalter S.
    Arch Phys Med Rehabil; 2012 Jun 15; 93(6):1081-5. PubMed ID: 22464095
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities.
    Tremlett H, Zhao Y, Devonshire V, UBC Neurologists.
    J Neurol; 2009 Mar 15; 256(3):374-81. PubMed ID: 19308306
    [Abstract] [Full Text] [Related]

  • 34. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D, Przuntek H, Sailer M, Bethke F, Koehler J, König N, Heesen C, Späth P, Andresen I.
    Mult Scler; 2007 Nov 15; 13(9):1107-17. PubMed ID: 17623736
    [Abstract] [Full Text] [Related]

  • 35. Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
    Roudbari SA, Ansar MM, Yousefzad A.
    J Neurol Sci; 2013 Jul 15; 330(1-2):52-5. PubMed ID: 23628463
    [Abstract] [Full Text] [Related]

  • 36. Clinical scales in progressive MS: predicting long-term disability.
    Bosma LV, Kragt JJ, Knol DL, Polman CH, Uitdehaag BM.
    Mult Scler; 2012 Mar 15; 18(3):345-50. PubMed ID: 21868487
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.
    Villar LM, Masjuan J, González-Porqué P, Plaza J, Sádaba MC, Roldán E, Bootello A, Alvarez-Cermeño JC.
    Ann Neurol; 2003 Feb 15; 53(2):222-6. PubMed ID: 12557289
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.